September 2020

Boston Scientific Announces Expanded Investment in and Exclusive Option to Acquire Farapulse, Inc.

United States - Massachusetts

Boston Scientific Corporation expanded its additional investment in and exclusive option to acquire Farapulse, Inc., a privately held company developing a pulsed field ablation system for the treatment of atrial fibrillation and other cardiac arrhythmias. Faegre Drinker represented Boston Scientific in the transaction. The financial terms were not disclosed. 

Read Boston Scientific’s press release for more information.

The Faegre Drinker Biddle & Reath LLP website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Drinker Biddle & Reath LLP's cookies information for more details.